| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_fd7c916555e5b01cd17634c7296d39b6 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-118
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-178
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2320-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-158
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2320-31
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K48-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2310-141 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-6886
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N15-113
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K48-00 |
| filingDate |
2009-07-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
2014-07-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_834d154e8d526b7b67dd65bef1edeb9a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8353fb6790ee3e1fcdbdc09d8724a80d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6a0a8ee26b655a50fa8430ea21b1ff7c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8f9123319f2b0c859d7001c45c83b900
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_104aa44f81819c6fd89d29b51aedbe6d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1d5a32ff1195d7f924cb4fea56083812 |
| publicationDate |
2014-07-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
CN-102387816-B |
| titleOfInvention |
Use of two microrna moleculars in lung caner prognosis and medicine preparation |
| abstract |
A composition comprising microRNA-150 and microRNA-886-3p, a device comprising the composition used in detection of lung cancer prognosis and the use of the composition in preparation of medicine for inhibiting mammal and human lung cancer metastasis are provided. The expression levels of the microRNA-150 and microRNA-886-3p can be used as the diagnostic criteria of lung cancer prognosis, and high expression level indicates favorable therapeutic effect. A method for detecting the expression level of the microRNA-150 and microRNA-886-3p in sample is provided too. |
| priorityDate |
2009-07-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |